Literature DB >> 23164687

Diurnal variation in serum alanine aminotransferase activity in the US population.

Constance E Ruhl1, James E Everhart.   

Abstract

GOALS AND
BACKGROUND: Serum alanine aminotransferase (ALT) activity has been reported to be greater in the afternoon than the early morning, but data are scarce. We examined diurnal variation of ALT in a national population-based sample. STUDY: Participants in the 1999 to 2008 US National Health and Nutrition Examination Survey were randomly assigned to morning (AM; n = 4474 adolescents, 11,235 adults) or afternoon/evening (PM; n = 4887 adolescents, 11,735 adults) examinations. We examined ALT distributions graphically and compared both geometric mean ALT and the prevalence of elevated ALT, defined as >31 IU/L for adolescent boys, >24 IU/L for adolescent girls, >43 IU/L for adult men, and >30 IU/L for adult women, between AM and PM examination groups.
RESULTS: The examination groups were similar with the exception in the AM group of a longer fasting time and slightly higher prevalence of diabetes among adolescents and viral hepatitis B among adult women. ALT distributions were similar between examination sessions among the 4 groups. Among adolescents and men, neither mean ALT nor prevalence of abnormal ALT differed by examination group. Among women, mean ALT was statistically significant, but minimally higher in the PM group (19.6 IU/L) than the AM group (19.1 IU/L; P = 0.009). Among 1 subgroup, women with chronic viral hepatitis, there was a higher prevalence of abnormal ALT in the PM group (P = 0.018 in unadjusted analysis). Adjusting for liver injury risk factors had little effect on the difference in mean ALT.
CONCLUSIONS: In general, clinically significant diurnal variation in ALT activity was not found in the US population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23164687      PMCID: PMC3545081          DOI: 10.1097/MCG.0b013e31826df40a

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  14 in total

Review 1.  Biological variation in clinical chemistry. An update: collated data, 1988-1991.

Authors:  C G Fraser
Journal:  Arch Pathol Lab Med       Date:  1992-09       Impact factor: 5.534

2.  Reference values for circadian rhythms of 98 variables in clinically healthy men in the fifth decade of life.

Authors:  E L Kanabrocki; R B Sothern; L E Scheving; D L Vesely; T H Tsai; J Shelstad; C Cournoyer; J Greco; H Mermall; H Ferlin
Journal:  Chronobiol Int       Date:  1990       Impact factor: 2.877

3.  Diurnal variation of serum alanine transaminase activity in chronic liver disease.

Authors:  J Córdoba; K O'Riordan; J Dupuis; J Borensztajin; A T Blei
Journal:  Hepatology       Date:  1998-12       Impact factor: 17.425

4.  The effect of sex, deviation from ideal weight and sampling time on blood constituents in presumably healthy subjects.

Authors:  E Panek; J Steinmetz
Journal:  Clin Chim Acta       Date:  1979-03-15       Impact factor: 3.786

5.  Factors contributing to intra-individual variation of serum constituents. 1. Within-day variation of serum constituents in healthy subjects.

Authors:  B E Statland; P Winkel; H Bokelund
Journal:  Clin Chem       Date:  1973-12       Impact factor: 8.327

6.  Intra-individual variation in commonly analyzed serum constituents.

Authors:  B Morrison; A Shenkin; A McLelland; D A Robertson; M Barrowman; S Graham; G Wuga; K J Cunningham
Journal:  Clin Chem       Date:  1979-10       Impact factor: 8.327

7.  Circadian rhythms of serum concentrations of 12 enzymes of clinical interest.

Authors:  A Rivera-Coll; X Fuentes-Arderiu; A Díez-Noguera
Journal:  Chronobiol Int       Date:  1993-06       Impact factor: 2.877

8.  Brief communication: clinical implications of short-term variability in liver function test results.

Authors:  Mariana Lazo; Elizabeth Selvin; Jeanne M Clark
Journal:  Ann Intern Med       Date:  2008-03-04       Impact factor: 25.391

Review 9.  Assessment of child and adolescent overweight and obesity.

Authors:  Nancy F Krebs; John H Himes; Dawn Jacobson; Theresa A Nicklas; Patricia Guilday; Dennis Styne
Journal:  Pediatrics       Date:  2007-12       Impact factor: 7.124

10.  Executive summary: Standards of medical care in diabetes--2010.

Authors: 
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

View more
  6 in total

1.  Comparison of hepatitis C virus testing strategies: birth cohort versus elevated alanine aminotransferase levels.

Authors:  Bryce D Smith; Anthony K Yartel
Journal:  Am J Prev Med       Date:  2014-09       Impact factor: 5.043

2.  Prevalence of increased transaminases and its association with sex, age, and metabolic parameters in children and adolescents with obesity - a nationwide cross-sectional cohort study.

Authors:  Resthie R Putri; Thomas Casswall; Emilia Hagman
Journal:  BMC Pediatr       Date:  2021-06-09       Impact factor: 2.125

3.  Association between Hepatic Steatosis and Obstructive Sleep Apnea in Children and Adolescents with Obesity.

Authors:  Marco Carotenuto; Anna Di Sessa; Maria Esposito; Anna Grandone; Pierluigi Marzuillo; Ilaria Bitetti; Giuseppina Rosaria Umano; Francesco Precenzano; Emanuele Miraglia Del Giudice; Nicola Santoro
Journal:  Children (Basel)       Date:  2021-11-01

Review 4.  Alanine aminotransferase-old biomarker and new concept: a review.

Authors:  Zhengtao Liu; Shuping Que; Jing Xu; Tao Peng
Journal:  Int J Med Sci       Date:  2014-06-26       Impact factor: 3.738

5.  Prevalence of Elevated Alanine Aminotransferase by Diagnostic Criterion, Age, and Gender among Adolescents.

Authors:  Jing Zhang; Zheng-Ying Wang; Jing-Ping Zhang; Hua Zhou; Zan Ding
Journal:  Gastroenterol Res Pract       Date:  2020-01-25       Impact factor: 2.260

6.  Circulating liver enzymes and risks of chronic diseases and mortality in the prospective EPIC-Heidelberg case-cohort study.

Authors:  Verena Katzke; Theron Johnson; Disorn Sookthai; Anika Hüsing; Tilman Kühn; Rudolf Kaaks
Journal:  BMJ Open       Date:  2020-03-08       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.